Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in m...
Q1 2026
May 13, 2026
FY 2025
Mar 27, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 11, 2025